LeadCare II Blood Lead Test Kit, containing LeadCare II Lead Controls Product Usage: IVD test...
FDA Device Recall #Z-3035-2017 — Class II — January 20, 2016
Recall Summary
| Recall Number | Z-3035-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 20, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Magellan Diagnostics, Inc. |
| Location | North Billerica, MA |
| Product Type | Devices |
| Quantity | 12,931 kits |
Product Description
LeadCare II Blood Lead Test Kit, containing LeadCare II Lead Controls Product Usage: IVD test kit for the detection of lead in blood. The kit consists of sensors, treatment reagent, lead controls (two levels), heparinized capillary tubes and plungers, transfer droppers and a calibration button. The LeadCare II Lead Controls packaged in the kit lots listed in #2 below are the subject of this recall (Field Correction) action.
Reason for Recall
LeadCare II Test Kits controls out of range
Distribution Pattern
Worldwide - US Nationwide distribution and the countries of: COLOMBIA, CANADA, THAILAND, INDIA, UAE, AUSTRALIA, GERMANY, CANADA, SOUTH AFRICA, SPAIN, NEW ZEALAND, KOREA
Lot / Code Information
Lot # :1507N Exp Date: 1/27/17; Lot # :1508N Exp Date: 2/27/17; Lot # :1510N Exp Date: 4/19/17; Lot # :1511M Exp Date: 5/3/17 Lot # :1511N Exp Date: 5/17/17 Lot # :1512M Exp Date: 6/2/17
Other Recalls from Magellan Diagnostics, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0584-2026 | Class II | The LeadCare¿ II Blood Lead Test System relies ... | Feb 23, 2024 |
| Z-0219-2024 | Class II | LeadCare II Blood Lead Test Kit-For in vitro di... | Sep 19, 2023 |
| Z-1953-2021 | Class I | LeadCare Plus Blood Lead Test Kit Catalog Numb... | May 7, 2021 |
| Z-1952-2021 | Class I | LeadCare II Blood Lead Test Kit Catalog Number... | May 7, 2021 |
| Z-1954-2021 | Class I | LeadCare Ultra Blood Lead Test Kit Catalog Num... | May 7, 2021 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.